Back

3D echocardiography and biomarkers for early diagnosis and prediction of chemotherapy induced right ventricular dysfunction in non-Hodgkin lymphoma patients

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Echocardiographic characterisation of myocardial function in heart failure 3D Echocardiography ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Diana Mihalcea

University of Medicine and Pharmacy Carol Davila, Bucharest (Romania)

9 More presentations in this session

Presentation thumbnail
Improvement of myocardial contractility after iron replacement in stable heart failure patients
Doctor C. Benavent Garcia (Elche, ES)
Abstract Slides Video
Presentation thumbnail
The implementation of speckle tracking echocardiography for cardiac resynchronization therapy optimization. A rotational myocardial mechanics interpretation.
Doctor A. Stefanidis (Pireas, GR)
Abstract Slides Video
Presentation thumbnail
Revisiting echocardiographic ranges of left ventricular end-diastolic volume index: an analysis of the discrepancies between the 2006 and the 2015 recommendation for chamber quantification guidelines
Associate Professor F. Larti (Tehran, IR)
Abstract Slides Video
Presentation thumbnail
Effects of cardiac resynchronization therapy and physiologicaL pacing on left atrioventricular coupling index: the REPHYL-LACI study
Doctor G. Sanna (Sassari, IT)
Abstract Slides Video
Presentation thumbnail
Diastolic dysfunction and survival in patients with preserved or mildly reduced left ventricular ejection fraction
Doctor N. Chan (Herston, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Echocardiographic characterisation of myocardial function in heart failure

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
The impact of antitumor therapy on cardiac systolic function in patients with non-hodgkin lymphoma
thumbnail
Congress Presentation
Multimodal predictive model for 6-month treatment-related cardiotoxicity in non-Hodgkin lymphoma patients
thumbnail
Congress Presentation
Discovery of novel imaging biomarkers for cardiotoxicity in a prospective longitudinal study of cancer patients receiving anthracyclines and chest radiotherapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources